5,422
edits
Ovarian cancer: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 158: | Line 158: | ||
In high-risk patients (BRCA, Lynch syndrome), we can do prophylactic bilateral salpingo-oophorectomy after the age of 35. | In high-risk patients (BRCA, Lynch syndrome), we can do prophylactic bilateral salpingo-oophorectomy after the age of 35. | ||
<section begin="gyntreatment" /> | <section begin="gyntreatment" /><section begin="borderline" /> | ||
== Management == | == Management == | ||
Most patients with epithelial ovarian carcinoma are treated by surgical removal or cytoreduction followed by adjuvant chemotherapy. Borderline tumours are managed like malignant epithelial tumours. | Most patients with epithelial ovarian carcinoma are treated by surgical removal or cytoreduction followed by adjuvant chemotherapy. Borderline tumours are managed like malignant epithelial tumours. | ||
| Line 184: | Line 184: | ||
=== Radiotherapy === | === Radiotherapy === | ||
Radiotherapy is not part of the standard management of ovarian cancer, but it may be used on a palliative indication for recurrent or metastatic ovarian cancer. | Radiotherapy is not part of the standard management of ovarian cancer, but it may be used on a palliative indication for recurrent or metastatic ovarian cancer.<section end="borderline" /> | ||
=== Germ cell tumours === | === Germ cell tumours === | ||